INS and gestational diabetes: No significant differences were observed in non-fasting glucose levels in T3 for women in N-GDM and O-GDM groups treated with diet (91.9 ± 16.4 and 96.3 ± 14.0 mg/dL, respectively), in those who used diet and metformin (98.4 ± 39.6 and 92 ± 3.0 mg/dL, respectively), in women who used diet plus insulin (80.8 ± 8.5 and 84.7 ± 12.0 mg/dL, respectively), or in those who used diet, metformin and insulin (80.8 ± 9.1 and 85.4 ± 13.5 mg/dL, respectively) (Figure 2B).